In silico analyses suggest that DNAJC25 mRNA expression is also reduced in breast cancer tissues, and high DNAJC25 mRNA expression is correlated with favorable post-progression survival in breast cancer [205]. The gene discussed is DNAJC25; the disease is breast carcinoma.